|
Originally published In Press as doi:10.1074/jbc.M413073200 on March 16, 2005
J. Biol. Chem., Vol. 280, Issue 20, 19858-19866, May 20, 2005
Recycling of the Membrane-anchored Chemokine, CX3CL1*
Guang-Ying Liu ,
Vathany Kulasingam ,
R. Todd Alexander ,
Nicolas Touret ,
Alan M. Fong ,
Dhavalkumar D. Patel , and
Lisa A. Robinson ¶
From the
The Hospital for Sick Children Research Institute and the University of Toronto, Toronto M5G 1X8, Canada and Thurston Arthritis Research Center, The University of North Carolina, Chapel Hill, North Carolina 27599-7280
CX3CL1 (fractalkine) plays an important role in inflammation by acting as both chemoattractant and as an adhesion molecule. As for other chemokines, expression of CX3CL1 is known to be regulated at the level of transcription and translation. The unique transmembrane structure of CX3CL1 raises the possibility of additional functional regulation by altering its abundance at the cell surface. This could be accomplished in principle by changes in traffic between subcellular compartments. To analyze this possibility we examined the subcellular distribution of CX3CL1 in human ECV-304 cells stably expressing untagged or green fluorescent protein-tagged forms of the chemokine. CX3CL1 was present in two distinct compartments, diffusely on the plasma membrane and in a punctate juxtanuclear compartment. The latter shared some features with, yet was distinct from the conventional endocytic pathway and may represent a specialized recycling subcompartment. Accordingly, surface CX3CL1 was found to be in dynamic equilibrium with the juxtanuclear vesicular compartment. Intracellular CX3CL1 co-localized with the SNARE (soluble N-ethylmaleimide factor attachment protein receptor) proteins syntaxin-13 and VAMP-3. Cleavage of VAMP-3 by tetanus toxin or impairment of syntaxin-13 function by expression of a dominant-negative allele inhibited the ability of internalized CX3CL1 to traffic back to the plasma membrane. These data demonstrate the existence of a dynamic, SNARE-mediated recycling of CX3CL1 from the cell surface to and from an endomembrane storage compartment. The intracellular storage depot may serve as a source of the chemokine that could be rapidly mobilized by stimuli.
Received for publication, November 19, 2004
, and in revised form, February 15, 2005.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Paediatrics, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. Tel.: 416-813-7654 (ext. 1745); Fax: 416-813-6271; E-mail: lisa.robinson{at}sickkids.ca.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. A. Truman, C. A. Ford, M. Pasikowska, J. D. Pound, S. J. Wilkinson, I. E. Dumitriu, L. Melville, L. A. Melrose, C. A. Ogden, R. Nibbs, et al.
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis
Blood,
December 15, 2008;
112(13):
5026 - 5036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hermand, F. Pincet, S. Carvalho, H. Ansanay, E. Trinquet, M. Daoudi, C. Combadiere, and P. Deterre
Functional Adhesiveness of the CX3CL1 Chemokine Requires Its Aggregation: ROLE OF THE TRANSMEMBRANE DOMAIN
J. Biol. Chem.,
October 31, 2008;
283(44):
30225 - 30234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. L. Jamieson, S. Shimizu, J. A. D'Ambrosio, O. Meucci, and A. Fatatis
CX3CR1 Is Expressed by Prostate Epithelial Cells and Androgens Regulate the Levels of CX3CL1/Fractalkine in the Bone Marrow: Potential Role in Prostate Cancer Bone Tropism
Cancer Res.,
March 15, 2008;
68(6):
1715 - 1722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lu, L. Li, K. Kuno, Y. Wu, T. Baba, Y.-y. Li, X. Zhang, and N. Mukaida
Protective Roles of the Fractalkine/CX3CL1-CX3CR1 Interactions in Alkali-Induced Corneal Neovascularization through Enhanced Antiangiogenic Factor Expression
J. Immunol.,
March 15, 2008;
180(6):
4283 - 4291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Callewaere, B. Fernette, D. Raison, P. Mechighel, A. Burlet, A. Calas, P. Kitabgi, S. M. Parsadaniantz, and W. Rostene
Cellular and Subcellular Evidence for Neuronal Interaction between the Chemokine Stromal Cell-Derived Factor-1/CXCL 12 and Vasopressin: Regulation in the Hypothalamo-Neurohypophysial System of the Brattleboro Rats
Endocrinology,
January 1, 2008;
149(1):
310 - 319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Clark, P. K. Yip, J. Grist, C. Gentry, A. A. Staniland, F. Marchand, M. Dehvari, G. Wotherspoon, J. Winter, J. Ullah, et al.
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain
PNAS,
June 19, 2007;
104(25):
10655 - 10660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Durkan, R. T. Alexander, G.-Y. Liu, M. Rui, G. Femia, and L. A. Robinson
Expression and Targeting of CX3CL1 (Fractalkine) in Renal Tubular Epithelial Cells
J. Am. Soc. Nephrol.,
January 1, 2007;
18(1):
74 - 83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Otero, M. Groettrup, and D. F. Legler
Opposite Fate of Endocytosed CCR7 and Its Ligands: Recycling versus Degradation
J. Immunol.,
August 15, 2006;
177(4):
2314 - 2323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Garton, P. J. Gough, and E. W. Raines
Emerging roles for ectodomain shedding in the regulation of inflammatory responses
J. Leukoc. Biol.,
June 1, 2006;
79(6):
1105 - 1116.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|